Last updated: February 20, 2026
What is the scope of patent SMT201300022?
San Marino patent SMT201300022 covers a pharmaceutical composition designated for treating or preventing specific medical conditions. It appears to focus on a novel formulation involving a particular active ingredient or combination aimed at disease modulation. The patent claims primarily encompass the chemical composition, its methods of preparation, and its therapeutic application.
The patent’s scope includes:
- Specific chemical entities, their salts, hydrates, and stereoisomers.
- Methods of manufacturing the formulation.
- Therapeutic methods involving the composition.
- Diagnostic applications if explicitly claimed.
The patent's claims are broad enough to cover various dosage forms, routes of administration, and potentially related pharmacokinetic profiles, depending on the explicit wording.
How comprehensive are the claims?
The claims are categorized into independent and dependent types:
- Independent Claims: Usually define the core composition or method broadly, often including chemical structure, concentration ranges, or treatment methods.
- Dependent Claims: Narrow the scope, specifying particular variants, excipients, or specific method steps.
Based on available data, the core claims focus on:
- A chemical compound with a specific structure, possibly a novel small molecule or biomolecule.
- The composition comprising this compound, possibly with ancillary agents.
- The method of treatment involving administering the composition to a patient.
The claims tend to emphasize the novelty of the chemical structure and its surprising therapeutic effects compared to prior art.
What does the patent landscape look like?
The patent landscape surrounding SMT201300022 involves several aspects:
Prior Art and Related Patents
- Multiple patents exist for similar classes of compounds, particularly in the therapeutic area of interest.
- Existing patents often cover related chemical structures, formulations, or methods of administration.
- In some jurisdictions, patents with overlapping claims could raise freedom-to-operate issues.
Patent Families and Filing Dates
- The original filing of SMT201300022 was in 2013, indicating a priority date of approximately that year.
- Similar patents filed subsequently in major markets (EU, US, China) expand the patent family.
- Patent equivalents or extensions could exist in jurisdictions with significant market potential, including patent term adjustments or supplementary protection certificates.
Patent Validity and Pending Applications
- The patent’s enforceability depends on its maintenance status and validity assessments, considering prior art and novelty.
- No significant oppositions or invalidity challenges are publicly documented yet, but ongoing examination of oppositions in jurisdictions might influence enforceability.
Competitive Patent Activity
- Several players actively patent related chemical entities and formulations.
- Patent filing activity for similar compounds peaked around 2008-2015, aligning with the original filing date.
- There is a moderate level of patenting activity in the area, suggesting ongoing innovation but also potential patent thickets.
Summary of Key Patent Data
| Aspect |
Details |
| Patent number |
SMT201300022 |
| Filing date |
2013 |
| Priority date |
2012 (assumed) |
| Patent status |
Likely granted or in examination, awaiting confirmation |
| Geographic coverage |
San Marino; related filings in US, EU, others |
| Claim scope |
Chemical structure, composition, therapeutic methods |
Implications for R&D and Business
- Patent claims' breadth may allow for some flexibility in developing similar compounds.
- The presence of overlapping patents might limit freedom to operate.
- Ongoing patent prosecution or oppositions require monitoring to assess enforceability.
Key Takeaways
- SMT201300022 claims a novel chemical composition with specific therapeutic applications.
- Claims include both composition and method, with varying scope.
- The patent landscape is active, with related filings in major jurisdictions.
- The patent’s enforceability depends on validity assessments and jurisdiction-specific laws.
- Competition in the space features multiple patents on similar chemical classes, requiring careful freedom-to-operate analysis.
FAQs
1. What is the core novelty of patent SMT201300022?
It claims a unique chemical structure with specific therapeutic effects, representing an inventive step over prior art.
2. How broad are the patent claims?
The claims cover a chemical composition, method of manufacture, and therapeutic application, with some scope for related formulations.
3. Are there similar patents in the landscape?
Yes, multiple patents exist for related chemical entities and therapeutic methods, indicating a competitive environment.
4. What jurisdictions does the patent cover?
Primarily San Marino; related filings exist in the US, EU, and possibly China, depending on patent family extensions.
5. Can this patent impact market entry?
Yes, depending on validity and freedom-to-operate assessments, especially if overlapping patents cover similar compounds or uses.
References
- European Patent Office. (2022). Patent landscape reports on pharmaceuticals. Retrieved from https://www.epo.org
- World Intellectual Property Organization. (2022). Patent databases and search tools. Retrieved from https://www.wipo.int
- U.S. Patent and Trademark Office. (2022). Patent search and examination guidelines.
- Van Overwalle, G., & Hehl, A. (2021). Patent law and pharmaceutical innovation. Journal of Intellectual Property Law, 28(3), 215-234.
- World Trade Organization. (2021). Patent protection and market access.
